Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard bolus vs low-dose continuous terlipressin infusion for acute esophageal variceal bleeding in liver cirrhosis
KCT0006107Phase 4Completed
- Sponsor
- Korea University Ansan Hospital
- Start
- Jan 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of terlipressin in Cirrhosis and esophageal varices (2 arms), sponsored by Korea University Ansan Hospital. Started Jan 2022; status: completed.
02
Drugs
terlipressin
03
Conditions
Cirrhosisesophageal varices
Beyond the preview
Go deeper on KCT0006107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006107.